Monday, 28 May 2018

You are here

The RheumNow Week in Review - 2 March 2018

Dr. Jack Cush reviews the news and highlights from the past week on RheumNow.com.

  1. FDG-PET Scans in large vessel vasculitis (eg, Takayasus) capable to detecting active disease with 85% sensitivity and 83% specificity. Abnormal PET during remission, predicts 5 fold high risk of relapse. https://t.co/r2r2oCk0Kj
  2. Viscosupplementation of the hip joint DOES NOT WORK in numerous RTCs - with little/no evidence of efficacy at 3 and 6 months. https://t.co/rOk9JJ8uYI
  3. Curcumin combined with boswellic acid shown to be effective in 201 osteoarthritis patients in a randomized, double-blind, placebo-controlled study. https://t.co/Mlai1P7Yww
  4. Anti-mitochondrial antibodies found with inflammatory myositis may be associated with severe cardiac involvement. 4/7 had necrotizing myopathy and 3/7 had other autoimmune Dz - PBC, autoimmune hepatitis, Psoriasis, Hashimoto’s https://t.co/bssYfmQXfl
  5. A substudy within the BeST study found that TNF inhibitor Rx associated with less Xray development of OA in DIP (but not PIP) joints - 2.3% less for every month of TNFi Rx. https://t.co/zh8WD2DUcW
  6. Of 134 RTX treated pts (mean 79 mos), 23 (17%) developed Hypogammaglobulinemia after a mean 64 mos & assoc w/ 4x risk of severe infections. Gammaglobulin <8 g/L at baseline was a predictor of hypogamma (HR 7.34), but MTX was protective (HR 0.26)    https://t.co/AMOtNAUeXR
  7. Hip Replacement Augments Longevity  http://rheumnow.com/content/hip-replacement-augments-longevity 
  8. Gout Crystal Deposition is Deeper than its Measures    http://rheumnow.com/content/gout-crystal-deposition-deeper-its-measures
  9. Probenecid Benefits Heart Failure   http://rheumnow.com/content/probenecid-benefits-heart-failure
  10. IL-18 Binding Protein Effective in Adult-Onset Still's Disease  http://rheumnow.com/content/il-18-binding-protein-effective-adult-onset-...

 

Disclosures: 
The author has received compensation as an advisor or consultant on this subject

Add new comment

More Like This

The RheumNow Week in Review – Methotrexate CIRT Study (5.25.18)

Dr. Jack Cush reviews this past week's news from RheumNow.com - the risk of Cutaneous and Systemic LE, increasing flu vaccination, higher risk of VTE, MPO predictions, new drug for GIOP and CIRT - MTX in cardiovascular risk patients.

ACR Leaders Lobby Capitol Hill for Help on Rising Costs and Access Barriers in Arthritis Care

Rheumatologists and rheumatology health professionals convened on Capitol Hill this week to urge legislative action on pressing policy issues affecting rheumatology care during the American College of Rheumatology’s Advocacy Leadership Conference, held May 16 -17, 2018 in Washington, D.C.

The RheumNow Week in Review – Modifiable Behavior (5.18.18)

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.  He discusses opioids, new approval for polyarticular JIA, running and osteoarthritis, and modifiable behaviors that influence outcomes. 

The RheumNow Week in Review - Nonadherence and Astronomic Costs (5.11.18)

Dr. Jack Cush reviews highlights, news and journal articles from the past week on RheumNow.com.

Rising Need for Weight Loss Counseling in Arthritic Patients

The CDC's May 4th MMWR reports that from 2002 to 2014, the prevalence of health care provider counseling for weight loss among adults with arthritis and overweight or obesity increased by 10% (from 35% to 45%).

Among the 54.4 million adults with doctor-diagnosed arthritis in the United States, 32.7% are overweight and 38.1% are obese. Moreover obesity is more prevalent among persons with arthritis than among those who do not have arthritis.